Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2009

01-11-2009 | Basic Science

Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinases

Authors: Alexa Klettner, Johann Roider

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 11/2009

Login to get access

Abstract

Purpose

Vascular endothelial growth factor (VEGF) is a fundamental factor for angiogenesis. It plays important roles in pathological conditions (e.g. the development of wet AMD), but also in the healthy organism) e.g. in maintaining the vasculature and supporting the retina). Recent therapies to treat the wet AMD focus on neutralizing VEGF indiscriminately. VEGF is constitutively expressed in the retina, but its expression is upregulated by various (noxious) stimuli, e.g. oxidative stress or hypoxia. Discrimination between constitutive expression of VEGF and its pathological upregulation might provide the possibility of focusing on inhibiting the pathological expression only. Here, we focused on the influence of different mitogen-activated protein kinase (MAPK) (p38, Erk, JNK) on the secretion and expression of VEGF, with or without being challenged by oxidative stress.

Methods

VEGF secretion was measured using a perfusion organ culture model; expression was examined in primary RPE culture and Western blotting.

Results

Constitutive VEGF expression and secretion can be diminished by inhibiting p38, while inhibiting Erk or JNK does not show a significant effect. When challenged with oxidative stress (250 µM t-butylhydroperoxide), VEGF expression and secretion increases and the influence of the MAPK changes: While p38 still accounts for about 30% of the secretion, Erk shows a similar influence. Inhibiting JNK presents conflicting results. In organ culture, inhibiting JNK significantly increases VEGF secretion after stimulation with 250 µM tBH, while with regard to VEGF expression in RPE cell culture, this effect could not be seen.

Conclusion

Constitutive and oxidative stress induced VEGF secretion, and expression is differently regulated, which might offer an opportunity to selectively inhibit pathological VEGF expression only.
Literature
3.
go back to reference El-Remessy AB, Bartoli M, Platt DH, Fulton D, Caldwell RB (2004) Oxidative stress inactivates VEGF survival signaling in rential endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 118:243–252, doi:10.1242/jcs.01612 CrossRef El-Remessy AB, Bartoli M, Platt DH, Fulton D, Caldwell RB (2004) Oxidative stress inactivates VEGF survival signaling in rential endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 118:243–252, doi:10.​1242/​jcs.​01612 CrossRef
4.
5.
go back to reference Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal Bevacizumab (Avastin) for neovascular AMD. Ophthalmol 113:363–372CrossRef Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal Bevacizumab (Avastin) for neovascular AMD. Ophthalmol 113:363–372CrossRef
6.
go back to reference Spitzer MS, Yoeruek E, Sierra A, Wallenfels B, Schraermeyer U, Spitzer B, Bartz-Schmidt KU, Szurman P (2007) Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells. Graefes Arch Clin Exp Ophthalmol 245:1835–1842CrossRef Spitzer MS, Yoeruek E, Sierra A, Wallenfels B, Schraermeyer U, Spitzer B, Bartz-Schmidt KU, Szurman P (2007) Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells. Graefes Arch Clin Exp Ophthalmol 245:1835–1842CrossRef
8.
go back to reference Josko J, Mazurek M (2004) Transcription factors having impact on VEGF gene expression in angiongenesis. Med Sci Monit 10:RA89–RA98PubMed Josko J, Mazurek M (2004) Transcription factors having impact on VEGF gene expression in angiongenesis. Med Sci Monit 10:RA89–RA98PubMed
9.
go back to reference Pages G, Berra E, Milanini J, Levy AP, Pouyssegur J (2000) Stress activated Protein Kinases (JNK and p38/HOG) are essential for Vascular Endothelial Growth Factor (VEGF) mRNA stability. J Biol Chem 275:26484–26491, doi:10.1074/jbc.M002104200 PubMedCrossRef Pages G, Berra E, Milanini J, Levy AP, Pouyssegur J (2000) Stress activated Protein Kinases (JNK and p38/HOG) are essential for Vascular Endothelial Growth Factor (VEGF) mRNA stability. J Biol Chem 275:26484–26491, doi:10.​1074/​jbc.​M002104200 PubMedCrossRef
10.
go back to reference Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP (2004) Insulin-like Growth Factor -1 (IGF-1) plays a pathogenetic role in diabetic retinopathy. Am J Pathol 165:457–469PubMed Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP (2004) Insulin-like Growth Factor -1 (IGF-1) plays a pathogenetic role in diabetic retinopathy. Am J Pathol 165:457–469PubMed
11.
go back to reference Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis A (2002) Acute insulin therapy exacerbates diabetic blood–retinal barrier breakdown via hypoxia - inducible factor 1 alpha and VEGF. J Clin Invest 109:805–815PubMed Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis A (2002) Acute insulin therapy exacerbates diabetic blood–retinal barrier breakdown via hypoxia - inducible factor 1 alpha and VEGF. J Clin Invest 109:805–815PubMed
12.
go back to reference Nagineni CN, Nagineni S, Samuel W, Pardhasaradhi K, Wiggert B, Detrick B, Hooks JJ (2003) TGF-ß induces expression of VEGF in human RPE cells: involvement of MAPK. J Cell Physiol 197:453–462, doi:10.1002/jcp.10378 PubMedCrossRef Nagineni CN, Nagineni S, Samuel W, Pardhasaradhi K, Wiggert B, Detrick B, Hooks JJ (2003) TGF-ß induces expression of VEGF in human RPE cells: involvement of MAPK. J Cell Physiol 197:453–462, doi:10.​1002/​jcp.​10378 PubMedCrossRef
21.
go back to reference Murata M, Yudoh K, Nakamura H, Kato T, Inoue K, Chiba J, Nishioka K, Masuko-Hongo K (2006) Distinct signaling pathways are involved in hypoxia- and IL-1-induced VEGF expression in human articular chondrocytes. J Orthop Res 24:1544–1554, doi:10.1002/jor.20168 PubMedCrossRef Murata M, Yudoh K, Nakamura H, Kato T, Inoue K, Chiba J, Nishioka K, Masuko-Hongo K (2006) Distinct signaling pathways are involved in hypoxia- and IL-1-induced VEGF expression in human articular chondrocytes. J Orthop Res 24:1544–1554, doi:10.​1002/​jor.​20168 PubMedCrossRef
22.
go back to reference Fan B, Wang YX, Yao T, Zhu YC (2005) p38 Mitogen-activated protein kinase mediates hypoxia-induced vascular endothelial growth factor release in human endothelial cells. Sheng Li Xue Bao 57:13–20PubMed Fan B, Wang YX, Yao T, Zhu YC (2005) p38 Mitogen-activated protein kinase mediates hypoxia-induced vascular endothelial growth factor release in human endothelial cells. Sheng Li Xue Bao 57:13–20PubMed
24.
go back to reference Hilfiker-Kleiner D, Hilfiker A, Kaminstki K, Schaefer A, Park JK, Michel K, Quint A, Yaniv M, Weitzman JB, Drexler H (2005) Lack of JunD promotes pressure overload - induced apoptosis, hypertrophic growth and angiogenesis in the heart. Circulation 112:1470–1477, doi:10.1161/CIRCULATIONAHA.104.518472 PubMedCrossRef Hilfiker-Kleiner D, Hilfiker A, Kaminstki K, Schaefer A, Park JK, Michel K, Quint A, Yaniv M, Weitzman JB, Drexler H (2005) Lack of JunD promotes pressure overload - induced apoptosis, hypertrophic growth and angiogenesis in the heart. Circulation 112:1470–1477, doi:10.​1161/​CIRCULATIONAHA.​104.​518472 PubMedCrossRef
26.
go back to reference Milanini J, Vinals F, Pouyssegur J, Pages G (1998) p42/p44 MAP Kinase module plays a key role in the transcriptional regualtion of the cascular endothelial growth factor (VEGF) gene in fibroblasts. J Biol Chem 273:18165–18172, doi:10.1074/jbc.273.29.18165 PubMedCrossRef Milanini J, Vinals F, Pouyssegur J, Pages G (1998) p42/p44 MAP Kinase module plays a key role in the transcriptional regualtion of the cascular endothelial growth factor (VEGF) gene in fibroblasts. J Biol Chem 273:18165–18172, doi:10.​1074/​jbc.​273.​29.​18165 PubMedCrossRef
28.
go back to reference Sodhi A, Montaner S, Miyazaki H, Gutkind JS (2001) MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1α in rasV12 upregulation of VEGF. Biochem Biophys Res Commun 287:292–300, doi:10.1006/bbrc.2001.5532 PubMedCrossRef Sodhi A, Montaner S, Miyazaki H, Gutkind JS (2001) MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1α in rasV12 upregulation of VEGF. Biochem Biophys Res Commun 287:292–300, doi:10.​1006/​bbrc.​2001.​5532 PubMedCrossRef
29.
go back to reference Sutton KM, Hayat S, Chau NM, Cook S, Pouyssegur J, Ahmed A, Perusinghe N, Le Floch R, Yang J, Ashcroft M (2007) Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1. Oncogene 26:3920–3929, doi:10.1038/sj.onc.1210168 PubMedCrossRef Sutton KM, Hayat S, Chau NM, Cook S, Pouyssegur J, Ahmed A, Perusinghe N, Le Floch R, Yang J, Ashcroft M (2007) Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1. Oncogene 26:3920–3929, doi:10.​1038/​sj.​onc.​1210168 PubMedCrossRef
30.
go back to reference Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R, Semenza G (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604–4613PubMed Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R, Semenza G (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604–4613PubMed
32.
go back to reference McMahon S, Charbonneau M, Grandmont S, Richard D, Dubois C (2006) Transforming growth factor beta 1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem 281:24171–24181, doi:10.1074/jbc.M604507200 PubMedCrossRef McMahon S, Charbonneau M, Grandmont S, Richard D, Dubois C (2006) Transforming growth factor beta 1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem 281:24171–24181, doi:10.​1074/​jbc.​M604507200 PubMedCrossRef
34.
go back to reference Friday BB, Adjei AA (2008) Advances in targeting the Ras/Raf/MEK/Erk mitogen activated protein kinase cascade with MEK inhibitors for cancer therapy. Mol Pathol 14:342–346 Friday BB, Adjei AA (2008) Advances in targeting the Ras/Raf/MEK/Erk mitogen activated protein kinase cascade with MEK inhibitors for cancer therapy. Mol Pathol 14:342–346
35.
go back to reference Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS (2005) Systemic Bevacizumab (Avastin) Therapy for Neovascular Age Related Macular Degeneration. Ophthalmol 112:1035–1047CrossRef Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS (2005) Systemic Bevacizumab (Avastin) Therapy for Neovascular Age Related Macular Degeneration. Ophthalmol 112:1035–1047CrossRef
36.
go back to reference Krishna M, Narang H (2008) The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci 65:3535–3544CrossRef Krishna M, Narang H (2008) The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci 65:3535–3544CrossRef
Metadata
Title
Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinases
Authors
Alexa Klettner
Johann Roider
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 11/2009
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-009-1139-x

Other articles of this Issue 11/2009

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2009 Go to the issue